IP Library Granted Patent US 9,024,056
Granted Patent B2
US 9,024,056 · App. 14/335,709 · Granted May 5, 2015

Crystalline form of 3-methylsulfonylpropionitrile

Inventors: Joseph P. St. Laurent (Lakeville, MA); Gerald S. Jones (Norwood, MA); David M. Bresse (Middleboro, MA)
Assignee: Olatec Industries LLC
C07C317/28C07C315/02C07C315/00C07C315/06C07C317/44C07B2200/13
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,024,056
App. No.
14/335,709
Granted
May 5, 2015
Kind
B2
Abstract

The present invention relates to processes for preparing 3-methylsulfonylpropionitrile. The processes provide a good yield and a good purity of the final product and provide a controllable reaction. The present invention also relates to a crystalline form of 3-methylsulfonylpropionitrile having X-ray diffraction peaks at 13.9±0.1, 19.2±0.1, 20.0±0.1, 22.5±0.1, 23.2±0.1, 25.7±0.1, 28.1±0.1, 29.9±0.1, and 30.6±0.1 degrees 2θ, and wherein the most intense peak is the peak at 13.9±0.1 degrees 2θ.

Claims (9)

1. A crystalline form of 3-methylsulfonylpropionitrile having X-ray diffraction peaks at 13.9±0.1, 19.2±0.1, 20.0±0.1, 22.5±0.1, 23.2±0.1, 25.7±0.1, 28.1±0.1, 29.9±0.1, and 30.6±0.1 degrees 2θ, and wherein the most intense peak is the peak at 13.9±0.1 degrees 2θ.

2. The crystalline form according to claim 1 , wherein 3-methylsulfonylpropionitrile is at least 95% pure.

3. The crystalline form according to claim 2 , wherein 3-methylsulfonylpropionitrile is at least 98% pure.

4. A crystalline form of 3-methylsulfonylpropionitrile having X-ray diffraction spectrum as shown in FIG. 2A .

5. The crystalline form according to claim 4 , wherein 3-methylsulfonylpropionitrile is at least 95% pure.

6. The crystalline form according to claim 5 , wherein 3-methylsulfonylpropionitrile is at least 98% pure.

7. A crystalline form of 3-methylsulfonylpropionitrile having X-ray diffraction spectrum as shown in FIG. 2D .

8. The crystalline form according to claim 7 , wherein 3-methylsulfonylpropionitrile is at least 95% pure.

9. The crystalline form according to claim 8 , wherein 3-methylsulfonylpropionitrile is at least 98% pure.

Assignments (2)
CHANGE OF NAME Recorded Nov 7, 2023
From: OLATEC THERAPEUTICS LLC
To: OLATEC THERAPEUTICS, INC.
Reel/Frame 065489/0809 →
CHANGE OF NAME Recorded Mar 18, 2016
From: OLATEC INDUSTRIES LLC
To: OLATEC THERAPEUTICS LLC
Reel/Frame 038177/0824 →
Continuity (3)
Division 13777754 · Feb 26, 2013
Provisional Application 61603744 · Feb 27, 2012
Related Publication 20140330037A1 · Nov 6, 2014